Valuation: EMV Capital plc

Market Cap 14.96M 20.26M 17.5M 16.46M 28.14M 1.94B 28.55M 193M 75.68M 971M 76.06M 74.41M 3.23B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 13.93M 18.87M 16.29M 15.33M 26.21M 1.81B 26.59M 180M 70.48M 904M 70.83M 69.29M 3.01B EV / Sales 2026 *
4.06x
EV / Sales 2027 * 4.05x
Free-Float
52.46%
Yield 2026 *
-
Yield 2027 * -
1 month+0.94%
3 months+11.46%
Current year-6.14%
1 week 52
Extreme 52
55
1 month 52
Extreme 52
55
Current year 44
Extreme 44
62
1 year 40
Extreme 40
62
3 years 34
Extreme 34
80.5
5 years 34
Extreme 34
137
10 years 9.75
Extreme 9.75
846
Manager TitleAgeSince
Chief Executive Officer 50 01/05/2020
Director of Finance/CFO 45 01/12/2025
Chief Investment Officer - -
Director TitleAgeSince
Director/Board Member 50 14/10/2019
Director/Board Member 47 09/12/2022
Chairman 61 01/02/2023
Date Insider Type Main position Quantity % Market Cap.
1/8/26 A Buy 7,000 0.0250%
1/8/26 A Sell 7,000 0.0250%
12/19/25 A Buy

Director

34,484 0.1242%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%+5.94%-14.40% 20.28M
0.00%+2.44%+68.73%+32.44% 3.71B
+0.67%-0.12%-12.87%+1.46% 3.05B
-0.96%+4.10%+84.12%+180.39% 1.46B
0.00%0.00%-1.72%-7.02% 730M
-7.83%-1.35%+157.26%+224.22% 658M
0.00%0.00%-3.33%-7.05% 410M
0.00%0.00%-40.68%-75.18% 391M
0.00%+1.63%+0.54%-13.02% 371M
0.00%0.00%-2.79%-12.55% 369M
Average -0.69%+0.17%+25.52%+30.93% 1.12B
Weighted average by Cap. -0.32%+0.30%+37.82%+43.68%

Financials

2026 *2027 *
Net sales 3.43M 4.64M 4.01M 3.77M 6.45M 445M 6.54M 44.26M 17.35M 223M 17.43M 17.05M 741M 3.75M 5.08M 4.39M 4.13M 7.06M 487M 7.16M 48.43M 18.98M 243M 19.07M 18.66M 811M
Net income - -
Net Debt -1.03M -1.39M -1.2M -1.13M -1.94M -133M -1.96M -13.28M -5.2M -66.75M -5.23M -5.12M -222M 233K 315K 272K 256K 438K 30.2M 444K 3M 1.18M 15.1M 1.18M 1.16M 50.31M
Logo EMV Capital plc
EMV Capital plc is a United Kingdom-based deep tech and life sciences venture capital (VC) investment group with an international portfolio of companies. The Company identifies, invests in, and builds high-growth companies in the United Kingdom and internationally. It focuses on generating returns for investors from the sectors and technologies. The Company has a portfolio of approximately 70 companies with a focus on life sciences, industrials, robotics & artificial intelligence (AI), and sustainability. Its portfolio includes AMR Bio, Wanda Health, Deeptech Recycling Technologies, EpiBone, Sofant Technologies, Q-Bot, and others. Its portfolio, Glycotest, is a liver disease diagnostics company commercializing novel and unique blood tests for life-threatening liver cancers and fibrosis-cirrhosis. ProAxsis Limited is a commercial biomarker-led research company supporting drug development and clinical research through specialist biomarker insights.
Employees
21
Date Price Change Volume
18/08/26 GBX 53.50 0.00% 2,201
17/08/26 GBX 53.50 0.00% 1,604
14/08/26 GBX 53.50 0.00% 23,020
13/08/26 GBX 53.50 0.00% 3,855
12/08/26 GBX 53.50 0.00% 16,018
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.5350GBP
Average target price
1.320GBP
Spread / Average Target
+146.73%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. EMVC Stock